@SAN DIEGO
June 7, 2020
San Diego, U.S.
ABOUT CHINA FOCUS @SAN DIEGO
China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.
China Focus @ SAN DIEGO is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.
- Investors (VC, PE, investment bank, etc.)
- Life science innovators and entrepreneurs
- Biotech & big pharma
- Medtech (device and diagnostics) manufacturers and distributors
- Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
- Healthcare providers
-
Cross-border investment: money from the East and the West
-
Innovations going to China: regulation, market access, manufacturing and distribution
-
Chinese innovations going west: partnership for capital and market access in the U.S.
- Learn about Chinese life science and healthcare industry
- Hear about the latest Chinese regulatory reforms and implications
- Meet with the decision makers in the industry
- Initiate business conversations that otherwise difficult to start
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events
| Ticket Type | Price | Cart |
|---|---|---|
| mianfei | $30 |
Attendees
Chinese Companies and Investors
%
Executive Level Attendees
One-to-one meetings
Download Sample Attendee List from past China Focus events
Download Program from past China Focus events
PAST SPEAKERS
(in alphabetical order by last name)
Bob Ai
Managing Director
Solebury Trout
Katherine Andersen
Head of U.S. Life Science & Healthcare Relationship Banking
Silicon Valley Bank
Gunjan Bhardwaj
CEO
Innoplexus AG
Cynthia Cai
Senior Advisor
Northern Light Venture Capital
Ping Cao
VP Business Development
Henlius Biotech
Greg Caressi
SVP, Transformational Health
Foster & Sullivan
Daniel Chai
Managing Partner
Turret Capital
Michelle Chen
VP, Head of Corporate Development
WuXi Biologics
Tom Du
Medical Partner
Shenzhen Share Capital
Martin Dueñas
Founder & CEO
OniX
Emmanuel Fobum
Global commercial strategy and Digital Innovation Leader
Johnson & Johnson
Sean Fu
President
Luye Boston R&D LLC
Alexander Gaffney
Sr. Manager
PwC Health Research Institute
Jimmy Hao
Partner
Fox Rothschild LLP
Echo Hindle-Yang
CEO
MSQ Ventures
Herwig Janssen
VP, Licensing & Acquisitions Emerging Markets
Janssen Pharmaceutica
Alan Jiang
Chief Strategy Officer
XtalPi
James Lee
Senior business development manager
Atomwise
Andy Li
President and CEO
BioSense Suzhou Global
Derrick Li
Head of Strategy and Investor Relations
Cellular Biomedicine Group
Weiwei Liang
Associate Director BD&L
Sandoz/Novartis
Brad Loncar
CEO
Loncar Investments
Bernice Ma
Assc Principal
Evolution Road LLC
Kim Nearing
Managing Director
Cedrus Group
Wendy Pan
Partner
Sidley Austin LLP
Rachel Sha
VP, Digital Business Development
Sanofi
Michael Song
Sr. Manager
MedImmune
Christian Soschner
CEO
CS Life Science Invest
Mark Tang
Managing Director
Good Health Capital
Weimin Tang
Head of Global business & Executive VP
I-Mab Biopharma
Danhui Wang
Managing Partner
Remedeca Partners LLC
Dayong Wang
VP Machine Learning
PathAI
Eric Wu
Director of Business Development
ReiStone Biopharma
Dan Zhang
CEO
Fountain Medical Development
Jianming Zhao
Deputy Division Director
Hangzhou Municipal Investment Promotion Bureau
Lily Zou
CEO
Fosun Pharma USA
PAST Participating Companies
Registration, Sponsorship and Collaboration (China)
Youwen (Allen) Dai
Registration, Sponsorship and Collaboration (U.S. and Europe)